• The company appointed a globally recognized diabetic foot care expert as Study Chair for its Phase 2a Nu-3 trial.
Two hundred and fifty years after declaring independence, the United States issues the currency that underwrites the global financial system. That status was not part of the founding design. It emerged in stages, was contested at each transition, and is being tested again. The …
• Quantum Corporation has drawn market attention after a share-price slide that has become a fresh test of tech-sector sentiment.
• RYTHM has drawn added market attention after a share-price decline that has renewed scrutiny of investor sentiment toward the name.
• Swarmer has moved into the spotlight after a notable share-price decline that has put its resilience to a high-volatility market test.
• Triller Group has drawn renewed market attention after a pronounced share-price fall that placed it among notable US decliners.
• U-BX Technology has moved into sharper market focus after a share-price pullback that has raised questions about near-term investor confidence.
• Unicycive Therapeutics has drawn heightened market attention after a sharp share-price decline that placed it among notable biotech decliners.
• Universe Pharmaceuticals has drawn heightened market attention after a notable share-price slide that placed it among the day's pharmaceutical decliners.
• Vince Holding has attracted renewed market attention after a share-price drop that has invited fresh scrutiny from retail investors.